AMCP

Our second annual Access Affordability and Outcomes: The Value of Managed Care Pharmacy report is now live! The report outlines the opportunities of managed care pharmacy and how industry professionals facilitate appropriate access to prescription treatments while remaining mindful of rising costs. We developed this resource to highlight the value of managed care pharmacy and its positive impact on the health care ecosystem and patients. We hope you enjoy reading it and find it useful! https://bit.ly/4eF4eau #AAOReport #managedcare #pharmacy #AMCPResearchInstitute

Are you a health care decision maker (HDCM) able to attend a preapproval information exchange (PIE) sessions? If so, please join us on November 4, 2024 at 2-3 pm ET for an AMCP PIE Webinar called A novel, once daily oral tablet being investigated as the first treatment for Hyperphagia in Prader-Willi Syndrome (PWS). During this free webinar, attendees will learn: Soleno Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of a novel therapy to treat Hyperphagia in Prader-Willi syndrome (PWS), a rare and life-threatening neurobehavioral, metabolic and endocrine disorder characterized by hyperphagia, neurocognitive and behavioral difficulties. The company is currently pursuing regulatory approval in the United States for its lead investigational candidate, DCCR (diazoxide choline) extended-release tablets. Register here: This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

Happy American Pharmacists Month! I always say public health is a team sport – and pharmacists, often a first point of care, are a crucial part of that team. Thank you, pharmacists, for all that you do to keep your communities healthy! 

Don’t miss your chance to honor an extraordinary leader and visionary pushing the boundaries of managed care! Acknowledge your esteemed colleague, role model, mentor, or professor by nominating them for #AMCPFdn’s Steven G. Avey Award! https://bit.ly/2SQ19Qd

During #AMCPNexus 2024 Charlles Dragovich, Senior Director and Client Strategist at Cencora, sat down with Managed Healthcare Executive to discuss the way regulations usually work and how the road to the Preapproval Information Exchange Act (PIE) was different! PIE was AMCP’s top legislative priority for many years and its passing represented the culmination of an advocacy process that was years in the making. Being able to share critical information with health plans and payers has expedited treatment delivery for millions of patients and AMCP is proud to have been a leading voice in the monumental effort! See the full interview below to hear more about PIE and its impact on patient outcomes! https://bit.ly/4fikoXi

New AMCP and Berkeley Research Group (BRG) found that patients who receive their medications through mail order pharmacies with a 90-day supply had the highest therapy adherence, with 80% or more days covered, compared to community pharmacies. AMCP’s Access Affordability and Outcomes report highlights the positive role managed care pharmacy plays in the health care industry and how it improves patient outcomes. Looking for more insights? Check out the report here: https://bit.ly/3BV1xD2

Chapman University’s Tinarena Awaradia, a PharmD candidate and current APPE student at AMCP, was honored with the CA AMCP Scholarship to attend the #AMCPNexus 2024 event in Las Vegas. This scholarship was in recognition of Tinarena’s dedication to the field of managed care pharmacy. We were elated to present this scholarship to Tinarena, who embodies the next generation of pharmacists that will strengthen the managed care pharmacy industry and improve patient outcomes. Read more on Tinarena and the scholarship at the blog below: https://bit.ly/3Ydq8dU

If you weren’t able to attend #AMCPNexus 2024 or just want a recap, Managed Healthcare Executive has a great “Week in Review,” capturing some of the top headlines coming out of the event, including treatment options for schizophrenia, the expected shift of Medicare beneficiaries towards Medicare Advantage Prescription Drug plans and cancer’s dominance of the drug development pipeline. Read more here: https://bit.ly/3A9NQzQ

Are you a health care decision maker (HDCM) able to attend a preapproval information exchange (PIE) sessions? If so, please join us on Wednesday, October 30, 2024 at 2-3 PM ET for an AMCP PIE Webinar called Vutrisiran Pre-Approval Information Exchange (PIE) Webinar. During this free webinar, attendees will learn: Transthyretin amyloidosis (ATTR) is an underdiagnosed, progressive, debilitating and fatal disease caused by misfolded transthyretin (TTR) proteins, which accumulate as amyloid deposits in various parts of the body, including the heart, nerves, and gastrointestinal tract. Please join Alnylam Pharmaceuticals as we review the disease state, clinical symptoms & epidemiology for the Cardiomyopathy manifestation of the disease followed by a review of the study results for the Phase 3 HELIOS-B trial. Register here: https://bit.ly/3AbMRPs This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

Great content, valuable sessions and invaluable networking opportunities at #AMCPNexus